Market closed · After hours · 5:35 PM ET
Last update: Oct 8, 2026, 5:17 PM ET
Market closed·71 changes confirmed today

Track the stock moves that actually matter.

BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.

1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s

Investment research built around change detection.

Showing:

BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
CSGP
CoStar Group, Inc.
$29.81
▲ 8.66%
Prev close $27.43
Oct 8, 2026 ET
⚡Material / Earnings✓High confidence

What changed: CoStar Group, Inc. (CSGP) moved +8.66% on 2026-10-08 after Needham & Company reiterated a 'buy' rating with a $40.00 price target. Volume was 2.1x the 5-day average.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

CSGP earnings are scheduled for 2026-10-27 with consensus EPS estimate of $0.34.

✓After hours - Last update: Oct 8, 2026, 4:44 PM ET
FRMI
Fermi Inc. Common Stock
$3.66
▼ 6.39%
Prev close $3.91
Oct 8, 2026 ET
🛡Material / Earnings✓High confidence

What changed: Fermi Inc. (FRMI) moved -6.39% from $3.91 to $3.66 on October 8, 2026, hitting a new 52-week low. The decline was driven by lingering dilution concerns from the company's recent upsized $350M–$431M convertible note offerings, anxiety over heavy operational cash burn and lack of near-term revenue for Project Matador, and negative public sentiment including critical commentary from Jim Cramer. Unresolved legal and corporate disputes involving ousted founder and former CEO Toby Neugebauer added to the overhang.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

FRMI earnings scheduled for November 9, 2026, with a consensus EPS estimate of −$0.04; cash position and runway disclosures will be critical to monitor.

✓After hours - Last update: Oct 8, 2026, 4:44 PM ET
ETSY
Etsy, Inc.
$75.14
▲ 5.62%
Prev close $71.14
Oct 8, 2026 ET
⚡Material / Earnings✓High confidence

What changed: Etsy, Inc. (ETSY) moved +5.62% on October 8, 2026, closing at $75.14, a new 30-day high. The move was driven by positive investor sentiment building on strong Q2 execution, upcoming holiday seasonal campaigns, and expansion of international payments infrastructure via Payoneer partnership.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Etsy is scheduled to report Q3 earnings on November 4, 2026, with consensus EPS estimate of $0.76.

✓After hours - Last update: Oct 8, 2026, 4:44 PM ET
COMP
Compass, Inc.
$9.52
▲ 5.66%
Prev close $9.01
Oct 8, 2026 ET
⚡Material / Earnings✓High confidence

What changed: Compass, Inc. (COMP) moved +5.66% from $9.01 to $9.52 on 2026-10-08. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move appears to be modest consolidation near the stock's recent $9.20 trading range on below-average volume (0.8x the 5-day mean).

Source: daily_prices:fmp_change_percent

Changes History →
What's next

COMP earnings report expected 2026-11-03.

✓After hours - Last update: Oct 8, 2026, 4:42 PM ET
UCTT
Ultra Clean Holdings, Inc.
$67.58
▼ 5.22%
Prev close $71.30
Oct 8, 2026 ET
🛡Material / Earnings✓High confidence

What changed: Ultra Clean Holdings, Inc. (UCTT) moved -5.22% from $71.30 to $67.58 on October 8, 2026, after analyst downgrades from firms including UBS and Zacks Research, and following the company's "Horizon 2030" strategy presentation that failed to generate near-term earnings momentum.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

UCTT earnings scheduled for October 27, 2026, with consensus EPS estimate of $0.94.

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
VSH
Vishay Intertechnology, Inc.
$34.56
▼ 5.11%
Prev close $36.42
Oct 8, 2026 ET
🛡Material / Earnings✓High confidence

What changed: Vishay Intertechnology, Inc. (VSH) moved −5.11% from $36.42 to $34.56 on 2026-10-08. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on below-average volume (0.6x the 5-day mean).

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Vishay's Q3 2026 earnings announcement on November 4, 2026 (before market open), with consensus EPS estimate of $0.28.

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
IONQ
IonQ, Inc.
$39.45
▼ 5.42%
Prev close $41.71
Oct 8, 2026 ET
🛡Material / Earnings✓High confidence

What changed: IonQ, Inc. (IONQ) moved -5.42% from $41.71 to $39.45 on 2026-10-08. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average (1.3x), suggesting typical trading activity.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

IONQ earnings announcement on 2026-11-04 (date not yet confirmed).

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
MXL
MaxLinear, Inc.
$93.70
▼ 9.50%
Prev close $103.54
Oct 8, 2026 ET
🛡Material / Earnings✓High confidence

What changed: MaxLinear, Inc. (MXL) moved -9.50% from $103.54 to $93.70 on October 8, 2026, amid a broad semiconductor and technology selloff. The stock, which had rallied over 400% year-to-date on optical data-center and AI infrastructure demand, faced profit-taking as the Nasdaq and S&P 500 retreated and investor sentiment shifted away from high-beta chip stocks.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

MaxLinear's Q3 2026 earnings report scheduled for late October 2026 (consensus EPS estimate $0.56) will test whether fundamental momentum supports the stock's elevated valuation.

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
STZ
Constellation Brands, Inc.
$123.63
▲ 5.51%
Prev close $117.17
Oct 8, 2026 ET
⚡Material / Earnings✓High confidence

What changed: Constellation Brands, Inc. (STZ) moved +5.51% on October 8, 2026, two days after reporting Q2 fiscal 2026 results that beat consensus: EPS of $3.74 vs. $3.62 estimate (+3.31% surprise) and revenue of $2.63 billion vs. $2.54 billion consensus (+6.1% year-over-year). Beer segment sales grew 5% and wine/spirits jumped 17%; management noted improved demand trends past Labor Day and reaffirmed full-year comparable EPS guidance of $11.20–$11.90, targeting the high end.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

STZ earnings scheduled for January 6, 2027 (consensus EPS estimate $2.77).

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
HSIC
Henry Schein, Inc.
$84.63
▲ 5.18%
Prev close $80.47
Oct 8, 2026 ET
⚡Material / Earnings✓High confidence

What changed: Henry Schein, Inc. (HSIC) moved +5.18% on October 8, 2026, after the company announced the appointment of Emmanuel Caprais, former ITT CFO, as incoming Senior Vice President and Chief Financial Officer, succeeding Ronald N. South. The announcement also included plans for broader organizational enhancements, including the addition of a Chief Strategy and Transformation Officer.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

HSIC earnings scheduled for November 3, 2026, with consensus EPS estimate of $1.36.

✓After hours - Last update: Oct 8, 2026, 4:39 PM ET
LDOS
Leidos Holdings, Inc.
$119.22
▲ 5.82%
Prev close $112.66
Oct 8, 2026 ET
⚡Material / Earnings✓High confidence

What changed: Leidos Holdings, Inc. (LDOS) moved +5.82% from $112.66 to $119.22 on October 8, 2026, following the closure of its security-screening joint venture with Analogic. The move was also supported by positive investor sentiment around its Q2 2026 earnings results and ongoing momentum from AI-driven cyber and air-traffic modernization contracts.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Leidos is scheduled to report Q3 2026 earnings on November 3, 2026, at 8 a.m. ET, with consensus EPS estimated at $3.05.

✓After hours - Last update: Oct 8, 2026, 10:02 AM ET
RVMD
Revolution Medicines, Inc.
$188.12
▼ 6.35%
Prev close $200.87
Oct 8, 2026 ET
📊Valuation✓High confidence

What changed: Revolution Medicines fell 6.19% to $188.43 as investors engaged in profit-taking on high-flying biotech stocks amid technical weakness and recent insider selling disclosures, according to web sources tracking the October 8 session. The decline occurred despite the company's announcement of patient enrollment in its Phase 3 RASolute 309 trial for metastatic pancreatic cancer, suggesting the positive operational update was overshadowed by sector-wide valuation digestion following a sustained multi-month rally.

Detected Oct 8, 3:50 PM ET

Source: Yahoo Finance ↗

Changes History →
What's next

RVMD earnings on November 4, 2026 (consensus EPS estimate: –$2.35); monitor for any updates on RASolute 309 enrollment pace and management commentary on insider transactions.

Latest research

View all research →

In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.

An abstract visualization of a sharply rising stock chart over restaurant and dining motifs with a question-mark overlay, in warm amber and green tones, representing Chipotle's surge on an unconfirmed Starbucks takeover report.
Stock AnalysisOctober 8, 2026 · 9 min read

Chipotle (CMG) Surges ~6% on a Report Starbucks Explored a Takeover

Chipotle jumped about 6% to roughly $32.54 on October 8 — after running as high as about $33.40 — on a Financial Times report that Starbucks has explored a potential takeover of the burrito chain. The key word is explored: the report describes preliminary, exploratory interest, not a formal offer, and neither company confirmed a deal, so this is a stock moving on takeover speculation that could reverse if the idea goes no further. The speculation still landed hard — volume ran about three times normal — because a Starbucks–Chipotle combination would be enormous (nearly $50 billion in combined sales, potentially the largest restaurant deal ever if completed) and would reunite Starbucks CEO Brian Niccol with the chain he ran from 2018 to 2024. It resonated partly because Chipotle had become cheap for Chipotle: down about 19% over the past year and trading below the ~$44 average analyst target even after the pop, a high-quality, cash-generative brand at a discount is exactly the profile that draws suitors. But skepticism is warranted: Starbucks fell about 3% on the prospect of a $45-billion-plus deal that would strain its balance sheet mid-turnaround, the strategic fit between coffee and fast-casual Mexican is debatable, and exploratory interest frequently never becomes an offer. The classic M&A-speculation cross-section — target up, acquirer down, McDonald's higher — tells the story; the next hard data is Chipotle's October 28 earnings.

An abstract visualization of a rising stock chart over data-storage and server-rack motifs with an upward target ladder, in blue and teal tones, representing NetApp's rise on an analyst upgrade in an AI-storage re-rating.
Stock AnalysisOctober 7, 2026 · 10 min read

NetApp (NTAP) Rises ~3.5% as Evercore Upgrades to a Street-High $300 on AI Storage

NetApp outperformed a weaker broader market on October 7, rising about 3.5% to roughly $236.50 after Evercore ISI's Amit Daryanani upgraded the stock from In Line to Outperform and set a Street-high $300 price target, up from $210. The move was less about one call than the cluster behind it: over roughly a week, Loop Capital went to $260, TD Cowen to $250, and Goldman to $240, and Evercore has now leapfrogged them all with a rating upgrade — a sell-side re-rating of NetApp as an AI-storage beneficiary, its all-flash arrays and ONTAP software positioned for the data pipelines that feed GPU clusters (a story reinforced by its late-September deal to buy PEAK:AIO and its Novus launch, both earlier developments rather than a fresh catalyst). NetApp rose even as long-dated Treasury yields hit their highest since 2002 in a rates- and oil-driven risk-off that pressured high-multiple shares. But the stock is not cheap: up roughly 96% over the past year, it trades near 23 times forward earnings and 6 times sales for a business growing revenue in the low-double-digits, so the upgrades are betting AI lifts both growth and the multiple. And the Street is genuinely split — the published average target near $206 sits below the price, reflecting both the lag before the newest hikes propagate and real disagreement: a camp of fresh below-price targets (Wedbush's Hold at $170, plus Citi, Barclays and Bank of America in the $190–$220 range) against the bulls at $240–$300. Without an unusually heavy-volume surge, this is a sell-side re-rating; the fundamentals arrive with December 1 earnings.

An abstract visualization of a sharply rising stock chart over vaccine-vial and molecular motifs in blue and teal tones, representing Vaxcyte's surge after its 31-valent pneumococcal vaccine cleared a pivotal Phase 3 trial.
Stock AnalysisOctober 5, 2026 · 9 min read

Vaxcyte (PCVX) Surges ~35% as VAX-31 Meets All Primary Endpoints in Pivotal Phase 3 Trial

Vaxcyte surged to roughly $76 on October 5 — up about 35% after opening near $87 (about +54%) — when it reported positive topline data from OPUS-1, the pivotal adult Phase 3 trial of VAX-31, its 31-valent pneumococcal conjugate vaccine. The trial met all of its prespecified primary endpoints on immune-response and safety measures: in adults 50 and older, VAX-31 met non-inferiority on all 20 serotypes it shares with Pfizer's Prevnar 20 and 17 of the 19 it shares with Merck's Capvaxive (the two exceptions cleared only a less-stringent historical bar), and superiority on the three serotypes unique to VAX-31, with safety similar to the incumbents. It is the profile a broader, 31-valent shot needs to take share in a multi-billion-dollar adult pneumococcal market — and the market priced it as a transfer of value, with Pfizer down about 1.6% and Merck about 3.4% while the biotech index was flat. Vaxcyte is still a clinical-stage, pre-revenue company — a roughly $1 billion annual loss, no P/E, and years from revenue, with two more Phase 3 trials due in 2027 and a planned filing in 2028 — but about $2.5 billion of cash and investments gives it runway, and sell-side targets sit well above the current price (Guggenheim raised its target to $125 the same day; Mizuho and Jefferies reiterated standing Buys at $163 and $146). The stock's gap-up-then-fade captures the tension between clearly good data and the execution still ahead.

An abstract visualization of a sharply rising stock chart meeting a fixed price line, over engineering-software and product-design motifs in blue and green tones, representing PTC's jump on an all-cash takeover by Schneider Electric.
Stock AnalysisOctober 5, 2026 · 10 min read

PTC Inc. (PTC) Jumps ~35% as Schneider Electric Agrees to a $22.6 Billion Cash Takeover

PTC Inc. jumped about 35% to roughly $194.49 on October 5 after Schneider Electric agreed to acquire the industrial-software maker in an all-cash deal at $205 a share — valuing PTC's equity near $22.6 billion, a 42.3% premium to Friday's close, in what would be Schneider's largest acquisition ever. With a firm cash bid in hand, the stock stopped trading on fundamentals and started trading on deal arithmetic: it gapped toward the offer but settled about 5% below it, a merger spread that prices the time and risk to a close expected by the third quarter of 2027, subject to a PTC shareholder vote and antitrust and CFIUS clearances. The logic is industrial software and AI — PTC's design and lifecycle tools (Creo, Windchill) carry an 84% gross margin and about $935 million of free cash flow, and the company had de-rated with the software group on AI fears, which is what made it available at a price Schneider would pay a premium over. The deal is also a read-through for the sector: design-software peers like Autodesk and Dassault Systèmes rose in sympathy as the price reframed what these assets are worth, while Loop Capital, Baird and Rosenblatt all moved PTC toward Hold/Neutral at the deal price — the textbook reaction to a fixed cash bid. The investment question now is simply whether the deal closes.

An abstract visualization of a declining stock chart over hard-disk-drive platters and data-storage motifs in cool blue and steel tones, representing Western Digital's drop on fears of new hard-drive supply.
Stock AnalysisOctober 2, 2026 · 9 min read

Western Digital (WDC) Drops ~10% as Toshiba Plans to Double AI/Data-Center HDD Capacity

Western Digital fell about 10% to roughly $415.50 intraday on October 2 after a report, traced to Nikkei, that Toshiba plans to double its production capacity for the high-capacity hard drives used in AI data centers — a roughly ¥60 billion (about $380 million) investment centered on the Philippines, for its fiscal year ending March 2028. The move had nothing to do with Western Digital itself: the stock's run, up about 216% over the past year, was built on a concentrated, supply-disciplined HDD industry keeping drive prices and margins firm, and a credible new source of capacity from the smallest of the three makers directly challenges that. It was a hard-drive-specific supply scare amid a broadly firm tech tape, not a tech selloff — Seagate, the other pure HDD maker, fell about 12%, while Micron slipped under 1% and Nvidia rose. As a pure-play HDD company after spinning off its flash business as SanDisk, Western Digital has no segment to cushion a pricing threat, and at roughly 21 times forward earnings and 12 times sales its premium multiple embeds an assumption that constrained supply keeps pricing elevated. The analyst picture is bullish — a Buy consensus averaging near $665 — but it predates the Toshiba report, and the open question is how far those targets come down as the Street weighs what added supply means for pricing.

An abstract visualization of a sharply declining stock chart over a fracturing shield and mortgage-and-credit-score motifs in deep blue and red tones, representing Fair Isaac's crash as regulators put a rival credit score on equal footing.
Stock AnalysisSeptember 30, 2026 · 9 min read

Fair Isaac (FICO) Crashes ~26% as FHFA Moves to Equalize VantageScore Mortgage Pricing

Fair Isaac fell about 26.5% to $617.87 on September 29 — its steepest single-day decline in decades — after FHFA Director Bill Pulte said, in a post late the prior evening, that Fannie Mae and Freddie Mac will move to a single mortgage pricing grid that treats loans scored with Classic FICO and rival VantageScore 4.0 equally, removing the 20-point adjustment that had kept FICO the default. The move strikes FICO's most profitable franchise: its Scores segment runs ~90% operating margins, and the company had just doubled its wholesale mortgage royalty to about $10.00 per score for 2026, while VantageScore 4.0's mortgage score is $0.99 (TransUnion committed through 2028) — so lenders now face a rival score that is roughly ten times cheaper and, once the change takes effect, priced identically by the GSEs. The repricing landed predominantly on FICO: the two publicly traded bureaus that jointly own VantageScore, Equifax and TransUnion, fell materially less — about 3% — and the S&P 500 was flat. Volume ran about seven times normal, and the stock is now down roughly 69% from its 52-week high. Analyst targets are splitting between a stale ~$1,435 consensus and fresh, event-aware resets — Huber Research downgraded to Underweight at $710, while Goldman cut to $1,322 but kept a Buy — capturing how uncertain the migration path is. After the drop FICO trades near 12 times forward earnings, but the multiple now hinges on how fast lenders actually switch.